News Archives - Page 391 of 721

ThursdayJul 22, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Preview Milestones for Novel Psychedelic Therapies in Investor Day Event

Tryp Therapeutics is a drug developer whose mission is to find novel solutions to conditions with otherwise unmet needs The company has distinguished itself by developing a synthetic oral psilocybin product that it aims to use in the treatment of chronic pain and eating disorder indications under its psychedelic medicine research program Tryp’s management team will address investors in a Fiscal Q3 review on July 29 that also serves as an opportunity to talk about upcoming milestones for the company Venture capital investment interest in psychedelic therapies has grown explosively from $1 million in 2017 to $329 million during the…

WednesdayJul 21, 2021 9:30 am

The DeFi Conference 2021 Tackles The Challenges of the Decentralized Finance Industry

5th August 2021 Pricing-Free The Decentralized Finance (“DeFi”) Industry offers a vast set of opportunities and has its set of challenges, with market finance volatility and risks increasing accordingly. The DeFi Conference 2021 is being held on 5th August 2021. This one-day free online event is a great learning and informative platform for businesses, academics, investors, and entrepreneurs to better understand the decentralized finance industry and explore the opportunities that this space offers. The DeFi Conference 2021 is organized by Bitcoin Events, a pioneer events company that hosts world-class bitcoin and blockchain conferences in Africa. The event will bring forth…

WednesdayJul 21, 2021 9:30 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

CNS Pharmaceuticals has been granted FDA Fast Track Designation for Berubicin due to the serious unmet medical need for new GBM treatments Enrollment into the potentially pivotal study for Berubicin and glioblastoma multiforme (“GBM”) in adults is already underway CNS Pharmaceuticals also secures additional funding of $4.7 million for pivotal study and operations into Q2 2022, adding to company’s significant accomplishments in short time CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system, achieved several fundamental clinical, corporate, and regulatory milestones over the…

WednesdayJul 21, 2021 9:00 am

Friendable Inc. (FDBL) Reports Major Milestone of 5,000 Fan Pass Artist Sign-ups, Shares New Corporate Presentation

The new version of the Fan Pass platform (v2.0) for mobile and desktop is scheduled for release one year after its debut, with new and improved offerings outlined in a new corporate presentation Artists and fans both benefit from the updated version, gaining an easy-to-use dashboard that tracks ticket and merchandise sales (for artists) and special access into the lives of the artists (for fans) Friendable estimates that if three celebrity partners with 10 million followers each marketed the Fan Pass platform and 1% of those followers subscribed, that would bring 300,000 new subscribers to the artist streaming platform A…

WednesdayJul 21, 2021 9:00 am

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

New numbers project that cannabis beverage market will reach $2.8 billion by 2025 Increasing demand for the health and wellness drinks is contributing to market growth BevCanna’s scalable, flexible manufacturing process provides white label solutions for third-party companies A new report that forecasts the cannabis beverage market will grow at 17.85% CAGR by 2025 has companies such as BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) anticipating increased numbers as well (https://ibn.fm/zh9Pa). A leader in the space, BevCanna is looking to leverage its position in the growing market as a white label manufacturer of infused-cannabis beverage brands. According to a…

WednesdayJul 21, 2021 9:00 am

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

2021 Sequire Blockchain Conference presentations now available on demand Conference featured over 15 established and emerging companies across blockchain, cryptocurrency spaces Keynote speakers included Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella, Brittany Kaiser SRAX (NASDAQ: SRAX), a leading financial technology company that helps public companies unlock the power of data through its Sequire SaaS platform, recently hosted the 2021 Sequire Blockchain Conference (https://ibn.fm/fTW6e), featuring over 15 leading blockchain and cryptocurrency-focused companies along with a slew of industry experts, including Brock Pierce, Maja Vujinovic, Saum Noursalehi, George Stella and Brittany Kaiser. Brock Pierce is a prominent entrepreneur, philanthropist, blockchain pioneer,…

TuesdayJul 20, 2021 9:30 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment

Former head of psychiatry products at FDA joins Cybin team. Laughren will help company plot its regulatory pathway as it studies and develops psychedelic medicines. Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, is making strategic moves as it progresses with pre-clinical and clinical trials. One of those steps includes the company’s recent announcement that Thomas Laughren is joining Cybin’s clinical advisory board (https://ibn.fm/q0abz). A medical doctor who served as the director of the U.S. Food and Drug Administration’s division of psychiatry products for nearly three decades, Laughren will help the company plot its regulatory…

TuesdayJul 20, 2021 9:30 am

Golden Triangle Ventures Inc. (GTVH) Exec Releases Update on Entertainment Division

GTVH has new office space to develop, manage, market all company ventures Lavish Entertainment’s goal is to “throw the most epic raves in the world” Founder notes spinoff of two companies slated to happen after GTVH completes audited financials Golden Triangle Ventures (OTC: GTVH) has announced key milestones reached by its entertainment division, which owns Lavish Entertainment Inc. and is doing business as EpicRaves. GTVH president Steffan Dalsgaard provided a summary of the division’s impressive progress in a mid-year letter to shareholders (https://ibn.fm/bikQI). In the letter, Dalsgaard noted significant progress made by the company’s entertainment division, including moving into new…

TuesdayJul 20, 2021 9:00 am

Q1 Report Shows Signs of Rising, Record-level Contracts for AmpliTech Group Inc.’s (NASDAQ: AMPG) Radio Frequency Technologies

AmpliTech Group, a designer and developer of technology that enhances radio frequency (“RF”) transmissions for satellites, 5G, IoT and other applications recently reported record order bookings and orders in progress under deadline Thaw in COVID pandemic’s business impact is very encouraging for future business opportunities Products serve satellite communications, space, telecommunications (5G/6G) and military defense markets Recapitalized and listed on Nasdaq to support variety of growth opportunities Cash position of approximately $30M - with no debt Radio Frequency component designer and manufacturer AmpliTech Group (NASDAQ: AMPG) recently reported record bookings and a record backlog (defined as contractually obligated purchase orders…

TuesdayJul 20, 2021 9:00 am

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis

Science continues to substantiate use of cannabis for pain relief, epileptic seizure control Research suggests strains with optimized cannabinoid profiles are more effective PACR produces premium top-quality strains cultivated using genetics-first approach to optimize cannabinoid profiles Genetic cultivation techniques allow selection for specific growing environments, maximum yields With a growing list of use cases spanning pain relief to seizure control, the medicinal use of cannabis goes back thousands of years (https://ibn.fm/X68wD). Pac Roots Cannabis (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM), a Canadian cannabis company, leverages a genetics-focused approach to producing premium-quality strains with optimum cannabinoid profiles that are prized among…

Site Search

Company Search

Category: News

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Set to Preview Milestones for Novel Psychedelic Therapies in Investor Day Event

The DeFi Conference 2021 Tackles The Challenges of the Decentralized Finance Industry

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) to Begin Patient Dosing in Berubicin Phase 2 Clinical Trial During Q3 2021, and Received Fast Track Designation from FDA

Friendable Inc. (FDBL) Reports Major Milestone of 5,000 Fan Pass Artist Sign-ups, Shares New Corporate Presentation

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Looks to Leverage Position in Growing Infused-Cannabis Space

Keynote Speaker Presentations from SRAX Inc.’s (NASDAQ: SRAX) 2021 Sequire Blockchain Conference Now Available on Demand

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces New Board Appointment

Golden Triangle Ventures Inc. (GTVH) Exec Releases Update on Entertainment Division

Q1 Report Shows Signs of Rising, Record-level Contracts for AmpliTech Group Inc.’s (NASDAQ: AMPG) Radio Frequency Technologies

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Leverages Genetic Technology to Produce First-In-Class Medical Grade Cannabis

Market Basics

Newsletter Publishers

Public Companies